Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Shares Issued (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Shares Issued for 5 consecutive years, with $745000.0 as the latest value for Q3 2025.

  • Quarterly Shares Issued changed N/A to $745000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $745000.0 through Dec 2025, down 18.49% year-over-year, with the annual reading at $745000.0 for FY2025, 18.49% down from the prior year.
  • Shares Issued for Q3 2025 was $745000.0 at Caribou Biosciences, up from -$468000.0 in the prior quarter.
  • The five-year high for Shares Issued was $319.9 million in Q3 2021, with the low at -$10.4 million in Q4 2024.
  • Average Shares Issued over 4 years is $30.9 million, with a median of $745000.0 recorded in 2025.
  • The sharpest move saw Shares Issued skyrocketed 230036.69% in 2021, then crashed 1978.84% in 2024.
  • Over 4 years, Shares Issued stood at $319.9 million in 2021, then tumbled by 100.16% to -$501000.0 in 2023, then plummeted by 1978.84% to -$10.4 million in 2024, then surged by 107.15% to $745000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $745000.0, -$468000.0, and $468000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.